Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%
- Check15 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.0%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, indicating a minor core-content update; the 'Back to Top' link was removed as a small UI change.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to include new facility and location information, as well as additional publications related to acute myeloid leukemia and myelodysplastic syndromes. Notably, the revision number has changed to v3.0.0.SummaryDifference6%
- Check50 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.6%
Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.